drugset / Trial / NCT01958177

Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia

NCT01958177

Phase 1/2 Unknown 20 enrolled Chaitanya Hospital, Pune
NaSingle-groupOpen-labelTreatment

Summary

Cerebellar ataxia is a complex motor disturbance, which, can occur as a result of many diseases and presents with symptoms of an inability to coordinate balance, gait, extremity and eye movements. Lesions to the cerebellum can cause dyssynergia, dysmetria, dysdiadochokinesia, dysarthria and ataxia of stance and gait. Deficits are observed with movements on the same side of the body as the lesion (ipsilaterally).

Timeline

Start
2014-09
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous bone marrow mononuclear cells Cell therapy Intravenous

Indications